GE Healthcare Technologies Inc. GEHC 深 滬
已收盤 02-06 16:00:00 美东时间
80.65
-1.660
-2.02%
華盛通- 最 高83.50
- 今 開82.48
- 成交量 346.89万股
- 最 低 80.46
- 昨 收 82.31
- 總市值 367.56亿
- 52周最高 93.12
- 市盈率 靜 17.72
- 換手率 0.76%
- 52周最低 57.51
- 委 比 -81.92%
- 總股本 4.56亿
- 歷史最高 94.66
- 量 比 0.80
- 振 幅 3.69%
- 歷史最低 53.115
- 每 手 1
- 風險率 6.67%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 谷歌绩后获14家大行上调目标价；Arm、高通、波士顿科学、艾可菲、Snap、优步遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Wave Life Sciences Ltd."超配"评级，目标价从34美元升至41美元；Piper Sandler：维持Replimune Group"超配"评级，目标价从13美元升至14美元
02-06 16:52
财报速睇 | GE Healthcare Technologies Inc. 2025财年Q4营收56.98亿美元，同比增长7.1%；归母净利润5.89亿美元，同比下滑18.2%
华盛资讯2月5日讯，GE Healthcare Technologies Inc.公布2025财年Q4业绩，公司Q4营收56.98亿美元，同比增长7.1%，归母净利润5.89亿美元，同比下滑18.2%。
02-05 16:35
美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价
今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元
02-05 11:28
GE HealthCare Techs Earnings Report: Q4 Overview
The earnings results for GE HealthCare Techs (NASDAQ:GEHC) for Q4 were made pub...
02-04 19:38
GE HealthCare Techs Q4 Adj. EPS $1.44 Beats $1.40 Estimate, Sales $5.698B Beat $5.611B Estimate
GE HealthCare Techs (NASDAQ:GEHC) reported quarterly earnings of $1.44 per share which beat the analyst consensus estimate of $1.40 by 3 percent. This is a 0.69 percent decrease over earnings of $1.45 per share from the
02-04 19:21
GE HealthCare reports Q4 revenues of USD 5.70 billion, up 7.1%
GE HealthCare reports Q4 revenues of USD 5.70 billion, up 7.1% GE HealthCare Technologies Inc. reported its financial results for the fourth quarter and full year ended December 31, 2025. For the fourth quarter, net income attributable to shareholders was USD 589 million. For the full year 2025, net
02-04 19:20
Earnings Scheduled For February 4, 2026
Companies Reporting Before The Bell • Oaktree Specialty Lending (NASDAQ:OCSL) i...
02-04 19:11
GE HealthCare Receives FDA 510(k) Clearance and CE Mark for Allia Moveo
GE HealthCare Receives FDA 510(k) Clearance and CE Mark for Allia Moveo GE HealthCare Technologies Inc. announced that its Allia Moveo platform has received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Marking. The Allia Moveo system is designed to enhance mobility and precision i
02-02 21:02
美股大行评级 | 苹果、SanDisk、西部数据、卡特彼勒、德克斯户外、霍尼韦尔、西南航空、万事达等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Praxis Precision Medicine"买入"评级，目标价从340美元升至1245美元；HC Wainwright & Co.：维持Perspective Therapeutics"买入"评级，目标价从10美元升至12美元
02-02 14:15
Piper Sandler Maintains Overweight on GE HealthCare Techs, Raises Price Target to $94
Piper Sandler analyst Jason Bednar maintains GE HealthCare Techs (NASDAQ:GEHC) with a Overweight and raises the price target from $91 to $94.
01-30 23:45
